Urine as a source for clinical proteome analysis: From discovery to clinical application

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1844, Issue 5, 2014, Pages 884-898

  Rodríguez Suárez, Eva ^a   Siwy, Justyna ^a,b   Zürbig, Petra ^a   Mischak, Harald ^a,c  

^a MOSAIQUES DIAGNOSTICS GMBH   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Biomarker; Proteomics; Urine

Indexed keywords

BIOLOGICAL MARKER; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 5; CXCL1 CHEMOKINE; INTER ALPHA TRYPSIN INHIBITOR; INTER ALPHA TRYPSIN INHIBITOR HEAVY CHAIN H4; IRBESARTAN; PLACEBO; PROSTATE SPECIFIC ANTIGEN; PROTEOME; UNCLASSIFIED DRUG;

ACUTE APPENDICITIS; ACUTE KIDNEY FAILURE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANALYTIC METHOD; APPENDECTOMY; APPENDICITIS; BLADDER CANCER; BRAIN ISCHEMIA; CANCER PATIENT; CAPILLARY ELECTROPHORESIS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CLINICAL EVALUATION; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; CYSTECTOMY; DIABETIC NEPHROPATHY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT VERSUS HOST REACTION; HEART FAILURE; HISTOPATHOLOGY; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY; MASS SPECTROMETRY; MICROALBUMINURIA; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NON INVASIVE PROCEDURE; NONHUMAN; PATHOPHYSIOLOGY; PERSONALIZED MEDICINE; PLASMA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREECLAMPSIA; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN MICROARRAY; PROTEIN URINE LEVEL; PROTEOMICS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMIC VASCULITIS; TANDEM MASS SPECTROMETRY; THEORETICAL MODEL; TWO DIMENSIONAL ELECTROPHORESIS; URETEROPELVIC JUNCTION OBSTRUCTION; URINALYSIS; URINE; UROGENITAL SYSTEM; UROLITHIASIS; VESICOURETERAL REFLUX;

BIOMARKER; PROTEOMICS; URINE;

BIOLOGICAL MARKERS; CLINICAL MEDICINE; HUMANS; PROTEINS; PROTEOME; PROTEOMICS; URINE;

EID: 84898599281     PISSN: 15709639     EISSN: 18781454     Source Type: Journal    
DOI: 10.1016/j.bbapap.2013.06.016     Document Type: Review

References (179)

1. J. Adachi, C. Kumar, Y. Zhang, J.V. Olsen, and M. Mann The human urinary proteome contains more than 1500 proteins including a large proportion of membranes proteins Genome Biol. 7 2006 R80.1 R80.16
2. A. Albalat, H. Mischak, and W. Mullen Clinical application of urinary proteomics/peptidomics Expert Rev. Proteomics 8 2011 615
3. A. Alban, S.O. David, L. Bjorkesten, C. Andersson, E. Sloge, S. Lewis, and I. Currie A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard Proteomics 3 2003 36
4. C.O. Alebiosu, and O.E. Ayodele The global burden of chronic kidney disease and the way forward Ethn. Dis. 15 2005 418
5. A. Alkhalaf, P. Zürbig, S.J. Bakker, H.J. Bilo, M. Cerna, C. Fischer, S. Fuchs, B. Janssen, K. Medek, H. Mischak, J.M. Roob, K. Rossing, P. Rossing, I. Rychlik, H. Sourij, B. Tiran, B.M. Winklhofer-Roob, and G.J. Navis Multicentric validation of proteomic biomarkers in urine specific for diabetic nephropathy PLoS One 5 2010 e13421
6. R.B. Ameur, L. Molina, C. Bolvin, C. Kifagi, F. Jarraya, H. Ayadi, F. Molina, and C. Granier Proteomic approaches for discovering biomarkers of diabetic nephropathy Nephrol. Dial. Transplant. 25 2010 2866
7. S. Andersen, H. Mischak, P. Zürbig, H.H. Parving, and P. Rossing Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria BMC Nephrol. 11 2010 29
8. N.G. Anderson, N.L. Anderson, and S.L. Tollaksen Proteins of human urine. I. Concentration and analysis by two-dimensional electrophoresis Clin. Chem. 25 1979 1199
9. G. Annoni, G. Luvara, B. Arosio, N. Gagliano, F. Fiordaliso, D. Santambrogio, G. Jeremic, L. Mircoli, R. Latini, C. Vergani, and S. Masson Age-dependent expression of fibrosis-related genes and collagen deposition in the rat myocardium Mech. Ageing Dev. 101 1998 57
10. J.R. Asplin Obesity and urolithiasis Adv. Chronic Kidney Dis. 16 2009 11
11. O.E. Ayodele, and C.O. Alebiosu Burden of chronic kidney disease: an international perspective Adv. Chronic Kidney Dis. 17 2010 215
12. F. Bandin, J. Siwy, B. Breuil, H. Mischak, J.L. Bascands, S. Decramer, and J.P. Schanstra Urinary proteome analysis at 5-year followup of patients with nonoperated ureteropelvic junction obstruction suggests ongoing kidney remodeling J. Urol. 187 2012 1006
13. M. Bantscheff, M. Schirle, G. Sweetman, J. Rick, and B. Kuster Quantitative mass spectrometry in proteomics: a critical review Anal. Bioanal. Chem. 389 2007 1017
14. E. Bujold, S. Roberge, Y. Lacasse, M. Bureau, F. Audibert, S. Marcoux, J.C. Forest, and Y. Giguere Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis Obstet. Gynecol. 116 2010 402
15. D.G. Bundy, J.S. Byerley, E.A. Liles, E.M. Perrin, J. Katznelson, and H.E. Rice Does this child have appendicitis? JAMA 298 2007 438
16. A.S. Calabuig, L. Guirado, and D. Ramos Prognostic significance and diagnosis of proteinuria in renal transplantation Transplant. Rev. (Orlando) 26 2012 30
17. G. Candiano, L. Musante, M. Bruschi, A. Petretto, L. Santucci, B.P. Del, B. Pavone, F. Perfumo, A. Urbani, F. Scolari, and G.M. Ghiggeri Repetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome J. Am. Soc. Nephrol. 17 2006 3139
18. R.J. Carreira, R. Rial-Otero, D. Lopez-Ferrer, C. Lodeiro, and J.L. Capelo Ultrasonic energy as a new tool for fast isotopic 18O labeling of proteins for mass spectrometry-based techniques: preliminary results Talanta 76 2008 400
19. D.M. Carty, J. Siwy, J.E. Brennand, P. Zürbig, W. Mullen, J. Franke, J.W. McCulloch, R.A. North, L.C. Chappell, H. Mischak, L. Poston, A.F. Dominiczak, and C. Delles Urinary proteomics for prediction of preeclampsia Hypertension 57 2011 561
20. T. Chaiworapongsa, R. Romero, J. Espinoza, E. Bujold, K.Y. Mee, L.F. Goncalves, R. Gomez, and S. Edwin Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award Am. J. Obstet. Gynecol. 190 2004 1541
21. M.J. Chalmers, C.L. Mackay, C.L. Hendrickson, S. Wittke, M. Walden, H. Mischak, D. Fliser, I. Just, and A.G. Marshall Combined top-down and bottom-up mass spectrometric approach to characterization of biomarkers for renal disease Anal. Chem. 77 2005 7163
22. Y.T. Chen, C.L. Chen, H.W. Chen, T. Chung, C.C. Wu, C.D. Chen, C.W. Hsu, M.C. Chen, K.H. Tsui, P.L. Chang, Y.S. Chang, and J.S. Yu Discovery of novel bladder cancer biomarkers by comparative urine proteomics using iTRAQ technology J. Proteome Res. 9 2010 5803
23. Y.T. Chen, H.W. Chen, D. Domanski, D.S. Smith, K.H. Liang, C.C. Wu, C.L. Chen, T. Chung, M.C. Chen, Y.S. Chang, C.E. Parker, C.H. Borchers, and J.S. Yu Multiplexed quantification of 63 proteins in human urine by multiple reaction monitoring-based mass spectrometry for discovery of potential bladder cancer biomarkers J. Proteomics 75 2012 3529
24. R.L. Chevalier Biomarkers of congenital obstructive nephropathy: past, present and future J. Urol. 172 2004 852
25. R.L. Chevalier, and C.A. Peters Congenital urinary tract obstruction: Proceedings of the State-Of-The-Art Strategic Planning Workshop-National Institutes of Health, Bethesda, Maryland, USA, 11-12 March 2002 Pediatr. Nephrol. 18 2003 576
26. J.J. Coon, P. Zürbig, M. Dakna, A.F. Dominiczak, S. Decramer, D. Fliser, M. Frommberger, I. Golovko, D.M. Good, S. Herget-Rosenthal, J. Jankowski, B.A. Julian, M. Kellmann, W. Kolch, Z. Massy, J. Novak, K. Rossing, J.P. Schanstra, E. Schiffer, D. Theodorescu, R. Vanholder, E.M. Weissinger, H. Mischak, and P. Schmitt-Kopplin CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics Proteomics Clin. Appl. 2 2008 964
27. P.R. Cutillas, R.J. Chalkley, K.C. Hansen, R. Cramer, A.G. Norden, M.D. Waterfield, A.L. Burlingame, and R.J. Unwin The urinary proteome in Fanconi syndrome implies specificity in the reabsorption of proteins by renal proximal tubule cells Am. J. Physiol. Renal Physiol. 287 2004 F353 F364
28. P.R. Cutillas, A.G. Norden, R. Cramer, A.L. Burlingame, and R.J. Unwin Detection and analysis of urinary peptides by on-line liquid chromatography and mass spectrometry: application to patients with renal Fanconi syndrome Clin. Sci. (Lond.) 104 2003 483
29. M. Dahlhaus, K.W. Li, R.C. Van der Schors, M.H. Saiepour, N.P. van, J.A. Heimel, J.M. Hermans, M. Loos, A.B. Smit, and C.N. Levelt The synaptic proteome during development and plasticity of the mouse visual cortex Mol. Cell. Proteomics 10 2011 M110
30. M. Dakna, K. Harris, A. Kalousis, S. Carpentier, W. Kolch, J.P. Schanstra, M. Haubitz, A. Vlahou, H. Mischak, and M. Girolami Addressing the challenge of defining valid proteomic biomarkers and classifiers BMC Bioinformatics 11 2010 594
31. J. Dawson, M. Walters, C. Delles, H. Mischak, and W. Mullen Urinary proteomics to support diagnosis of stroke PLoS One 7 2012 e35879
32. S. Decramer, P.A. Gonzalez de, B. Breuil, H. Mischak, B. Monsarrat, J.L. Bascands, and J.P. Schanstra Urine in clinical proteomics Mol. Cell. Proteomics 7 2008 1850
33. S. Decramer, S. Wittke, H. Mischak, P. Zürbig, M. Walden, F. Bouissou, J.L. Bascands, and J.P. Schanstra Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis Nat. Med. 12 2006 398
34. C. Delles, E. Schiffer, M.C. von Zur, K. Peter, P. Rossing, H.H. Parving, J.A. Dymott, U. Neisius, L.U. Zimmerli, J.K. Snell-Bergeon, D.M. Maahs, R.E. Schmieder, H. Mischak, and A.F. Dominiczak Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individuals J. Hypertens. 28 2010 2316
35. K. Dickstein, A. Cohen-Solal, G. Filippatos, J.J. McMurray, P. Ponikowski, P.A. Poole-Wilson, A. Stromberg, D.J. van Veldhuisen, D. Atar, A.W. Hoes, A. Keren, A. Mebazaa, M. Nieminen, S.G. Priori, and K. Swedberg ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur. Heart J. 29 2008 2388
36. B. Domon, and R. Aebersold Mass spectrometry and protein analysis Science 312 2006 212
37. A.S. Doria, R. Moineddin, C.J. Kellenberger, M. Epelman, J. Beyene, S. Schuh, P.S. Babyn, and P.T. Dick US or CT for diagnosis of appendicitis in children and adults? A meta-analysis Radiology 241 2006 83
38. J. Drube, E. Schiffer, E. Lau, C. Petersen, M. Kirschstein, M.J. Kemper, R. Lichtinghagen, B. Ure, H. Mischak, L. Pape, and J.H. Ehrich Urinary proteome analysis to exclude severe vesicoureteral reflux Pediatrics 129 2012 e356
39. J. Drube, P. Zürbig, E. Schiffer, E. Lau, B. Ure, S. Gluer, M. Kirschstein, L. Pape, S. Decramer, J.L. Bascands, J.P. Schanstra, H. Mischak, and J.H. Ehrich Urinary proteome analysis identifies infants but not older children requiring pyeloplasty Pediatr. Nephrol. 25 2010 1673
40. T.D. DuBose Jr., D.G. Warnock, R.L. Mehta, J.V. Bonventre, M.R. Hammerman, B.A. Molitoris, M.S. Paller, N.J. Siegel, J. Scherbenske, and G.E. Striker Acute renal failure in the 21st century: recommendations for management and outcomes assessment Am. J. Kidney Dis. 29 1997 793
41. M.W. Duncan, A.L. Yergey, and S.D. Patterson Quantifying proteins by mass spectrometry: the selectivity of SRM is only part of the problem Proteomics 9 2009 1124
42. V.M. Faca, K.S. Song, H. Wang, Q. Zhang, A.L. Krasnoselsky, L.F. Newcomb, R.R. Plentz, S. Gurumurthy, M.S. Redston, S.J. Pitteri, S.R. Pereira-Faca, R.C. Ireton, H. Katayama, V. Glukhova, D. Phanstiel, D.E. Brenner, M.A. Anderson, D. Misek, N. Scholler, N.D. Urban, M.J. Barnett, C. Edelstein, G.E. Goodman, M.D. Thornquist, M.W. McIntosh, R.A. DePinho, N. Bardeesy, and S.M. Hanash A mouse to human search for plasma proteome changes associated with pancreatic tumor development PLoS Med. 5 2008 e123
43. G.M. Fiedler, S. Baumann, A. Leichtle, A. Oltmann, J. Kase, J. Thiery, and U. Ceglarek Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry Clin. Chem. 53 2007 421
44. M. Frantzi, M. Makridakis, and A. Vlahou Biomarkers for bladder cancer aggressiveness Curr. Opin. Urol. 22 2012 390
45. S. Gauci, A.O. Helbig, M. Slijper, J. Krijgsveld, A.J. Heck, and S. Mohammed Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach Anal. Chem. 81 2009 4493
46. L.S. Geiss, W.H. Herman, M.G. Goldschmid, F. DeStefano, M.S. Eberhardt, E.S. Ford, R.R. German, J.M. Newman, D.R. Olson, and S.J. Sepe Surveillance for diabetes mellitus - United States, 1980-1989 MMWR CDC Surveill. Summ. 42 1993 1
47. R.E. Gerszten, and T.J. Wang The search for new cardiovascular biomarkers Nature 451 2008 949
48. D.M. Good, P. Zürbig, A. Argiles, H.W. Bauer, G. Behrens, J.J. Coon, M. Dakna, S. Decramer, C. Delles, A.F. Dominiczak, J.H. Ehrich, F. Eitner, D. Fliser, M. Frommberger, A. Ganser, M.A. Girolami, I. Golovko, W. Gwinner, M. Haubitz, S. Herget-Rosenthal, J. Jankowski, H. Jahn, G. Jerums, B.A. Julian, M. Kellmann, V. Kliem, W. Kolch, A.S. Krolewski, M. Luppi, Z. Massy, M. Melter, C. Neususs, J. Novak, K. Peter, K. Rossing, H. Rupprecht, J.P. Schanstra, E. Schiffer, J.U. Stolzenburg, L. Tarnow, D. Theodorescu, V. Thongboonkerd, R. Vanholder, E.M. Weissinger, H. Mischak, and P. Schmitt-Kopplin Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease Mol. Cell. Proteomics 9 2010 2424
49. K.L. Greene, J.E. Cowan, M.R. Cooperberg, M.V. Meng, J. DuChane, and P.R. Carroll Who is the average patient presenting with prostate cancer? Urology 66 2005 76
50. M. Haubitz, D.M. Good, A. Woywodt, H. Haller, H. Rupprecht, D. Theodorescu, M. Dakna, J.J. Coon, and H. Mischak Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in ANCA associated vasculitis Mol. Cell. Proteomics 8 2009 2296
51. A.O. Helbig, S. Gauci, R. Raijmakers, B.B. van, M. Slijper, S. Mohammed, and A.J. Heck Profiling of N-acetylated protein termini provides in-depth insights into the N-terminal nature of the proteome Mol. Cell. Proteomics 9 2010 928
52. C. Herder, M. Karakas, and W. Koenig Biomarkers for the prediction of type 2 diabetes and cardiovascular disease Clin. Pharmacol. Ther. 90 2011 52
53. J. Hernandez-Borges, C. Neususs, A. Cifuentes, and M. Pelzing On-line capillary electrophoresis-mass spectrometry for the analysis of biomolecules Electrophoresis 25 2004 2257
54. G.J. Hofmeyr, A. Roodt, A.N. Atallah, and L. Duley Calcium supplementation to prevent pre-eclampsia - a systematic review S. Afr. Med. J. 93 2003 224
55. M.M. Horowitz, R.P. Gale, P.M. Sondel, J.M. Goldman, J. Kersey, H.J. Kolb, A.A. Rimm, O. Ringden, C. Rozman, and B. Speck Graft-versus-leukemia reactions after bone marrow transplantation Blood 75 1990 555
56. G.L. Hortin, and D. Sviridov Diagnostic potential for urinary proteomics Pharmacogenomics 8 2007 237
57. P. Hovind, L. Tarnow, P. Rossing, B.R. Jensen, M. Graae, I. Torp, C. Binder, and H.H. Parving Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study BMJ 328 2004 1105
58. R. Huttenhain, M. Soste, N. Selevsek, H. Rost, A. Sethi, C. Carapito, T. Farrah, E.W. Deutsch, U. Kusebauch, R.L. Moritz, E. Nimeus-Malmstrom, O. Rinner, and R. Aebersold Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics Sci. Transl. Med. 4 2012 142ra94
59. D.A. Jacobsohn, M. Arora, J.P. Klein, A. Hassebroek, M.E. Flowers, C.S. Cutler, A. Urbano-Ispizua, B.J. Bolwell, J.H. Antin, M. Boyiadzis, J.Y. Cahn, M.S. Cairo, R.H. Herzig, L.M. Isola, T.R. Klumpp, S.J. Lee, E.W. Petersdorf, S. Santarone, R.P. Gale, H.C. Schouten, S.R. Spellman, D.J. Weisdorf, J.R. Wingard, M.M. Horowitz, and S.Z. Pavletic Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease Blood 118 2011 4472
60. K.K. Jain Role of pharmacoproteomics in the development of personalized medicine Pharmacogenomics 5 2004 331
61. D.J. Janecki, K.G. Bemis, T.J. Tegeler, P.C. Sanghani, L. Zhai, T.D. Hurley, W.F. Bosron, and M. Wang A multiple reaction monitoring method for absolute quantification of the human liver alcohol dehydrogenase ADH1C1 isoenzyme Anal. Biochem. 369 2007 18
62. J. Jantos-Siwy, E. Schiffer, K. Brand, G. Schumann, K. Rossing, C. Delles, H. Mischak, and J. Metzger Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease J. Proteome Res. 8 2009 268
63. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, T. Murray, and M.J. Thun Cancer statistics, 2008 CA Cancer J. Clin. 58 2008 71
64. L. Jia, L. Zhang, C. Shao, E. Song, W. Sun, M. Li, and Y. Gao An attempt to understand kidney's protein handling function by comparing plasma and urine proteomes PLoS One 4 2009 e5146
65. Z. Jiang, C.L. Wu, B.A. Woda, K. Dresser, J. Xu, G.R. Fanger, and X.J. Yang P504S/alpha-methylacyl-CoA racemase: a useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy Am. J. Surg. Pathol. 26 2002 1169
66. N. Johannesson, M. Wetterhall, K.E. Markides, and J. Bergquist Monomer surface modifications for rapid peptide analysis by capillary electrophoresis and capillary electrochromatography coupled to electrospray ionization-mass spectrometry Electrophoresis 25 2004 809
67. P. Jones, R.G. Cote, L. Martens, A.F. Quinn, C.F. Taylor, W. Derache, H. Hermjakob, and R. Apweiler PRIDE: a public repository of protein and peptide identifications for the proteomics community Nucleic Acids Res. 34 2006 D659 D663
68. B.A. Julian, S. Wittke, J. Novak, D.M. Good, J.J. Coon, M. Kellmann, P. Zürbig, E. Schiffer, M. Haubitz, Z. Moldoveanu, S.M. Calcatera, R.J. Wyatt, J. Sykora, E. Sladkova, O. Hes, H. Mischak, and B.M. McGuire Electrophoretic methods for analysis of urinary polypeptides in IgA-associated renal diseases Electrophoresis 28 2007 4469
69. T. Kaiser, H. Kamal, A. Rank, H.J. Kolb, E. Holler, A. Ganser, B. Hertenstein, H. Mischak, and E.M. Weissinger Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation Blood 104 2004 340
70. A. Kalela, T.A. Koivu, T. Sisto, J. Kanervisto, M. Hoyhtya, P. Sillanaukee, T. Lehtimaki, and S.T. Nikkari Serum matrix metalloproteinase-9 concentration in angiographically assessed coronary artery disease Scand. J. Clin. Lab. Invest. 62 2002 337
71. R.S. Kashyap, A.R. Nayak, P.S. Deshpande, D. Kabra, H.J. Purohit, G.M. Taori, and H.F. Daginawala Inter-alpha-trypsin inhibitor heavy chain 4 is a novel marker of acute ischemic stroke Clin. Chim. Acta 402 2009 160
72. R. Katz Biomarkers and surrogate markers: an FDA perspective NeuroRx 1 2004 189
73. H. Kawanishi, Y. Matsui, M. Ito, J. Watanabe, T. Takahashi, K. Nishizawa, H. Nishiyama, T. Kamoto, Y. Mikami, Y. Tanaka, G. Jung, H. Akiyama, H. Nobumasa, P. Guilford, A. Reeve, Y. Okuno, G. Tsujimoto, E. Nakamura, and O. Ogawa Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer Clin. Cancer Res. 14 2008 2579
74. A. Kentsis, S. Ahmed, K. Kurek, E. Brennan, G. Bradwin, H. Steen, and R. Bachur Detection and diagnostic value of urine leucine-rich alpha-2-glycoprotein in children with suspected acute appendicitis Ann. Emerg. Med. 60 2012 78
75. A. Kentsis, Y.Y. Lin, K. Kurek, M. Calicchio, Y.Y. Wang, F. Monigatti, F. Campagne, R. Lee, B. Horwitz, H. Steen, and R. Bachur Discovery and validation of urine markers of acute pediatric appendicitis using high-accuracy mass spectrometry Ann. Emerg. Med. 55 2010 62
76. A. Kentsis, F. Monigatti, K. Dorff, F. Campagne, R. Bachur, and H. Steen Urine proteomics for profiling of human disease using high accuracy mass spectrometry Proteomics Clin. Appl. 3 2009 1052
77. A. Kentsis, A. Shulman, S. Ahmed, E. Brennan, M.C. Monuteaux, Y.H. Lee, S. Lipsett, J.A. Paulo, F. Dedeoglu, R. Fuhlbrigge, R. Bachur, G. Bradwin, M. Arditi, R.P. Sundel, J.W. Newburger, H. Steen, and S. Kim Urine proteomics for discovery of improved diagnostic markers of Kawasaki disease EMBO Mol. Med. 5 2013 210
78. H. Keshishian, T. Addona, M. Burgess, D.R. Mani, X. Shi, E. Kuhn, M.S. Sabatine, R.E. Gerszten, and S.A. Carr Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution Mol. Cell. Proteomics 8 2009 2339
79. Y. Kim, V. Ignatchenko, C.Q. Yao, I. Kalatskaya, J.O. Nyalwidhe, R.S. Lance, A.O. Gramolini, D.A. Troyer, L.D. Stein, P.C. Boutros, J.A. Medin, O.J. Semmes, R.R. Drake, and T. Kislinger Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer Mol. Cell. Proteomics 11 2012 1870
80. Z. Kirkali, T. Chan, M. Manoharan, F. Algaba, C. Busch, L. Cheng, L. Kiemeney, M. Kriegmair, R. Montironi, W.M. Murphy, I.A. Sesterhenn, M. Tachibana, and J. Weider Bladder cancer: epidemiology, staging and grading, and diagnosis Urology 66 2005 4
81. D.S. Kirkpatrick, S.A. Gerber, and S.P. Gygi The absolute quantification strategy: a general procedure for the quantification of proteins and post-translational modifications Methods 35 2005 265
82. P.V. Kitsiou, A.K. Tzinia, W.G. Stetler-Stevenson, A.F. Michael, W.W. Fan, B. Zhou, and E.C. Tsilibary Glucose-induced changes in integrins and matrix-related functions in cultured human glomerular epithelial cells Am. J. Physiol. Renal Physiol. 284 2003 F671 F679
83. J. Klein, J. Eales, P. Zürbig, A. Vlahou, H. Mischak, and R. Stevens Proteasix: a tool for automated and large-scale prediction of proteases involved in naturally-occurring peptide generation Proteomics 13 2013 1077
84. M.A. Knepper Common sense approaches to urinary biomarker study design J. Am. Soc. Nephrol. 20 2009 1175
85. K. Koga, Y. Osuga, O. Yoshino, Y. Hirota, X. Ruimeng, T. Hirata, S. Takeda, T. Yano, O. Tsutsumi, and Y. Taketani Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia J. Clin. Endocrinol. Metab. 88 2003 2348
86. W. Kolch, H. Mischak, and A.R. Pitt The molecular make-up of a tumour: proteomics in cancer research Clin. Sci. (Lond.) 108 2005 369
87. W. Kolch, C. Neususs, M. Pelzing, and H. Mischak Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery Mass Spectrom. Rev. 24 2005 959
88. E. Kuhn, J. Wu, J. Karl, H. Liao, W. Zolg, and B. Guild Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards Proteomics 4 2004 1175
89. T. Kuznetsova, H. Mischak, W. Mullen, and J.A. Staessen Urinary proteome analysis in hypertensive patients with left ventricular diastolic dysfunction Eur. Heart J. 33 2012 2342
90. M.A. Kuzyk, D. Smith, J. Yang, T.J. Cross, A.M. Jackson, D.B. Hardie, N.L. Anderson, and C.H. Borchers Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma Mol. Cell. Proteomics 8 2009 1860
91. D.W. Landry, and H. Bazari Approach to the Patient With Renal Disease L. Goldman, D. Ausiello, Cecil Medicine 2011 Saunders Elsevier Philadelphia
92. A. Lapolla, L. Molin, A. Sechi, C. Cosma, E. Ragazzi, R. Seraglia, and P. Traldi A further investigation on a MALDI-based method for evaluation of markers of renal damage J. Mass Spectrom. 44 2009 1754
93. A. Lapolla, R. Seraglia, L. Molin, K. Williams, C. Cosma, R. Reitano, A. Sechi, E. Ragazzi, and P. Traldi Low molecular weight proteins in urines from healthy subjects as well as diabetic, nephropathic and diabetic-nephropathic patients: a MALDI study J. Mass Spectrom. 44 2009 419
94. B. Lee, D. Lopez-Ferrer, B.C. Kim, H.B. Na, Y.I. Park, K.K. Weitz, M.G. Warner, T. Hyeon, S.W. Lee, R.D. Smith, and J. Kim Rapid and efficient protein digestion using trypsin-coated magnetic nanoparticles under pressure cycles Proteomics 11 2011 309
95. C.F. Lee, S. Griffiths, E. Rodriguez-Suarez, A. Pierce, R.D. Unwin, E. Jaworska, C.A. Evans, J. Gaskell, and A.D. Whetton Assessment of downstream effectors of BCR/ABL protein tyrosine kinase using combined proteomic approaches Proteomics 10 2010 3321
96. A.S. Levey, K.U. Eckardt, Y. Tsukamoto, A. Levin, J. Coresh, J. Rossert, D. Zeeuw, T.H. Hostetter, N. Lameire, and G. Eknoyan Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO) Kidney Int. 67 2005 2089
97. F. Li, D.N. Chen, C.W. He, Y. Zhou, V.M. Olkkonen, N. He, W. Chen, P. Wan, S.S. Chen, Y.T. Zhu, K.J. Lan, and W.L. Tan Identification of urinary Gc-globulin as a novel biomarker for bladder cancer by two-dimensional fluorescent differential gel electrophoresis (2D-DIGE) J. Proteomics 77 2012 225
98. Q.R. Li, K.X. Fan, R.X. Li, J. Dai, C.C. Wu, S.L. Zhao, J.R. Wu, C.H. Shieh, and R. Zeng A comprehensive and non-prefractionation on the protein level approach for the human urinary proteome: touching phosphorylation in urine Rapid Commun. Mass Spectrom. 24 2010 823
99. M.D. Lindheimer, and D. Kanter Interpreting abnormal proteinuria in pregnancy: the need for a more pathophysiological approach Obstet. Gynecol. 115 2010 365
100. X.B. Ling, E.D. Mellins, K.G. Sylvester, and H.J. Cohen Urine peptidomics for clinical biomarker discovery Adv. Clin. Chem. 51 2010 181
101. A. Marimuthu, R.N. O'Meally, R. Chaerkady, Y. Subbannayya, V. Nanjappa, P. Kumar, D.S. Kelkar, S.M. Pinto, R. Sharma, S. Renuse, R. Goel, R. Christopher, B. Delanghe, R.N. Cole, H.C. Harsha, and A. Pandey A comprehensive map of the human urinary proteome J. Proteome Res. 10 2011 2734
102. L. Martens, H. Hermjakob, P. Jones, M. Adamski, C. Taylor, D. States, K. Gevaert, J. Vandekerckhove, and R. Apweiler PRIDE: the proteomics identifications database Proteomics 5 2005 3537
103. K. Matsushita, M. van der Velde, B.C. Astor, M. Woodward, A.S. Levey, P.E. de Jong, J. Coresh, and R.T. Gansevoort Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis Lancet 375 2010 2073
104. J.J. McMurray, and M.A. Pfeffer Heart failure Lancet 365 2005 1877
105. J.A. Medina-Aunon, S. Martinez-Bartolome, M.A. Lopez-Garcia, E. Salazar, R. Navajas, A.R. Jones, A. Paradela, and J.P. Albar The ProteoRed MIAPE web toolkit: a user-friendly framework to connect and share proteomics standards Mol. Cell. Proteomics 10 2011 M111
106. M.L. Merchant, B.A. Perkins, G.M. Boratyn, L.H. Ficociello, D.W. Wilkey, M.T. Barati, C.C. Bertram, G.P. Page, B.H. Rovin, J.H. Warram, A.S. Krolewski, and J.B. Klein Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria J. Am. Soc. Nephrol. 20 2009 2065
107. J. Metzger, T. Kirsch, E. Schiffer, P. Ulger, E. Mentes, K. Brand, E.M. Weissinger, M. Haubitz, H. Mischak, and S. Herget-Rosenthal Urinary excretion of twenty peptides forms an early and accurate diagnostic pattern of acute kidney injury Kidney Int. 78 2010 1252
108. W.G. Miller, D.E. Bruns, G.L. Hortin, S. Sandberg, K.M. Aakre, M.J. McQueen, Y. Itoh, J.C. Lieske, D.W. Seccombe, G. Jones, D.M. Bunk, G.C. Curhan, and A.S. Narva Current issues in measurement and reporting of urinary albumin excretion Clin. Chem. 55 2009 24
109. A.M. Minino, S.L. Murphy, J. Xu, and K.D. Kochanek Deaths: final data for 2008 Natl. Vital Stat. Rep. 59 2011 1
110. H. Mischak How to get proteomics to the clinic? Issues in clinical proteomics, exemplified by CE-MS Proteomics Clin. Appl. 6 2012 437
111. H. Mischak, G. Allmaier, R. Apweiler, T. Attwood, M. Baumann, A. Benigni, S.E. Bennett, R. Bischoff, E. Bongcam-Rudloff, G. Capasso, J.J. Coon, P. D'Haese, A.F. Dominiczak, M. Dakna, H. Dihazi, J.H. Ehrich, P. Fernandez-Llama, D. Fliser, J. Frokiaer, J. Garin, M. Girolami, W.S. Hancock, M. Haubitz, D. Hochstrasser, R.R. Holman, J.P. Ioannidis, J. Jankowski, B.A. Julian, J.B. Klein, W. Kolch, T. Luider, Z. Massy, W.B. Mattes, F. Molina, B. Monsarrat, J. Novak, K. Peter, P. Rossing, M. Sanchez-Carbayo, J.P. Schanstra, O.J. Semmes, G. Spasovski, D. Theodorescu, V. Thongboonkerd, R. Vanholder, T.D. Veenstra, E. Weissinger, T. Yamamoto, and A. Vlahou Recommendations for biomarker identification and qualification in clinical proteomics Sci. Transl. Med. 2 2010 46ps42
112. H. Mischak, C. Delles, J. Klein, and J.P. Schanstra Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application Adv. Chronic Kidney Dis. 17 2010 493
113. H. Mischak, J.P. Ioannidis, A. Argiles, T.K. Attwood, E. Bongcam-Rudloff, M. Broenstrup, A. Charonis, G.P. Chrousos, C. Delles, A. Dominiczak, T. Dylag, J. Ehrich, J. Egido, P. Findeisen, J. Jankowski, R.W. Johnson, B.A. Julien, T. Lankisch, H.Y. Leung, D. Maahs, F. Magni, M.P. Manns, E. Manolis, G. Mayer, G. Navis, J. Novak, A. Ortiz, F. Persson, K. Peter, H.H. Riese, P. Rossing, N. Sattar, G. Spasovski, V. Thongboonkerd, R. Vanholder, J.P. Schanstra, and A. Vlahou Implementation of proteomic biomarkers: making it work Eur. J. Clin. Invest. 42 2012 1027
114. H. Mischak, W. Kolch, M. Aivalotis, D. Bouyssie, M. Court, H. Dihazi, G.H. Dihazi, J. Franke, J. Garin, A. Gonzales de Peredo, A. Iphöfer, L. Jansch, C. Lacroix, M. Makridakis, C. Masselon, J. Metzger, B. Monsarrat, M. Mrug, M. Norling, J. Novak, A. Pich, A. Pitt, E. Bongcam-Rudloff, J. Siwy, H. Suzuki, V. Thongboonkerd, L. Wang, J. Zoidakis, P. Zürbig, J. Schanstra, and A. Vlahou Comprehensive human urine standards for comparability and standardization in clinical proteome analysis Proteomics Clin. Appl. 4 2010 464
115. H. Mischak, and P. Rossing Proteomic biomarkers in diabetic nephropathy - reality or future promise? Nephrol. Dial. Transplant. 25 2010 2843
116. H. Mischak, A. Vlahou, and J.P. Ioannidis Technical aspects and inter-laboratory variability in native peptide profiling: The CE-MS experience Clin. Biochem. 46 2013 432
117. L. Molin, R. Seraglia, A. Lapolla, E. Ragazzi, J. Gonzalez, A. Vlahou, J.P. Schanstra, A. Albalat, M. Dakna, J. Siwy, J. Jankowski, V. Bitsika, H. Mischak, P. Zurbig, and P. Traldi A comparison between MALDI-MS and CE-MS data for biomarker assessment in chronic kidney diseases J. Proteomics 75 2012 5888
118. C.J. Murray, and A.D. Lopez Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study Lancet 349 1997 1498
119. N. Nagaraj, and M. Mann Quantitative analysis of the intra- and inter-individual variability of the normal urinary proteome J. Proteome Res. 10 2011 637
120. K. Nakamura, T. Sasaki, X.W. Cheng, A. Iguchi, K. Sato, and M. Kuzuya Statin prevents plaque disruption in apoE-knockout mouse model through pleiotropic effect on acute inflammation Atherosclerosis 206 2009 355
121. C. Neususs, M. Pelzing, and M. Macht A robust approach for the analysis of peptides in the low femtomole range by capillary electrophoresis-tandem mass spectrometry Electrophoresis 23 2002 3149
122. G.R. Nicol, M. Han, J. Kim, C.E. Birse, E. Brand, A. Nguyen, M. Mesri, W. FitzHugh, P. Kaminker, P.A. Moore, S.M. Ruben, and T. He Use of an immunoaffinity-mass spectrometry-based approach for the quantification of protein biomarkers from serum samples of lung cancer patients Mol. Cell. Proteomics 7 2008 1974
123. E. Orenes-Pinero, M. Corton, P. Gonzalez-Peramato, F. Algaba, I. Casal, A. Serrano, and M. Sanchez-Carbayo Searching urinary tumor markers for bladder cancer using a two-dimensional differential gel electrophoresis (2D-DIGE) approach J. Proteome Res. 6 2007 4440
124. P. Picotti, and R. Aebersold Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions Nat. Methods 9 2012 555
125. A. Pierce, R.D. Unwin, C.A. Evans, S. Griffiths, L. Carney, L. Zhang, E. Jaworska, C.F. Lee, D. Blinco, M.J. Okoniewski, C.J. Miller, D.A. Bitton, E. Spooncer, and A.D. Whetton Eight-channel iTRAQ enables comparison of the activity of six leukemogenic tyrosine kinases Mol. Cell. Proteomics 7 2008 853
126. S. Principe, Y. Kim, S. Fontana, V. Ignatchenko, J.O. Nyalwidhe, R.S. Lance, D.A. Troyer, R. Alessandro, O.J. Semmes, T. Kislinger, R.R. Drake, and J.A. Medin Identification of prostate-enriched proteins by in-depth proteomic analyses of expressed prostatic secretions in urine J. Proteome Res. 11 2012 2386
127. L.F. Quintana, J.M. Campistol, M.P. Alcolea, E. Banon-Maneus, A. Sol-Gonzalez, and P.R. Cutillas Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction Mol. Cell. Proteomics 8 2009 1658
128. T. Rabilloud Two-dimensional gel electrophoresis in proteomics: old, old fashioned, but it still climbs up the mountains Proteomics 2 2002 3
129. J.C. Rajapakse, K.B. Duan, and W.K. Yeo Proteomic cancer classification with mass spectrometry data Am. J. Pharmacogenomics 5 2005 281
130. P.V. Rao, X. Lu, M. Standley, P. Pattee, G. Neelima, G. Girisesh, K.V. Dakshinamurthy, C.T. Roberts Jr., and S.R. Nagalla Proteomic identification of urinary biomarkers of diabetic nephropathy Diabetes Care 30 2007 629
131. N. Rifai, M.A. Gillette, and S.A. Carr Protein biomarker discovery and validation: the long and uncertain path to clinical utility Nat. Biotechnol. 24 2006 971
132. M.T. Rocchetti, M. Centra, M. Papale, G. Bortone, C. Palermo, D. Centonze, E. Ranieri, P.S. Di, and L. Gesualdo Urine protein profile of IgA nephropathy patients may predict the response to ACE-inhibitor therapy Proteomics 8 2008 206
133. E. Rodriguez-Suarez, and A.D. Whetton The application of quantification techniques in proteomics for biomedical research Mass Spectrom. Rev. 32 2013 1
134. S.S. Roscioni, Z.D. de, M.E. Hellemons, H. Mischak, P. Zurbig, S.J. Bakker, R.T. Gansevoort, H. Reinhard, F. Persson, M. Lajer, P. Rossing, and H.J. Heerspink A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus Diabetologia 56 2012 259
135. K. Rossing, H. Mischak, M. Dakna, P. Zürbig, J. Novak, B.A. Julian, D.M. Good, J.J. Coon, L. Tarnow, and P. Rossing Urinary proteomics in diabetes
136. K. Rossing, H. Mischak, P. Rossing, J.P. Schanstra, A. Wiseman, and D.M. Maahs The urinary proteome in diabetes and diabetes-associated complications: new ways to assess disease progression and evaluate therapy Proteomics Clin. Appl. 2 2008 997
137. D.H. Russell, and R.D. Edmondson High-resolution mass spectrometry and accurate mass measurements with emphasis on the characterization of peptides and proteins by matrix-assisted laser desorption/ionization time-of-ñight mass spectrometry J. Mass Spectrom. 32 1997 263
138. S. Schaub, J. Wilkins, T. Weiler, K. Sangster, D. Rush, and P. Nickerson Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry Kidney Int. 65 2004 323
139. S. Schaub, J.A. Wilkins, M. Antonovici, O. Krokhin, T. Weiler, D. Rush, and P. Nickerson Proteomic-based identification of cleaved urinary beta2-microglobulin as a potential marker for acute tubular injury in renal allografts Am. J. Transplant. 5 2005 729
140. E. Schiffer, C. Bick, B. Grizelj, S. Pietzker, and W. Schofer Urinary proteome analysis for prostate cancer diagnosis: Cost-effective application in routine clinical practice in Germany Int. J. Urol. 19 2012 118
141. E. Schiffer, A. Vlahou, A. Petrolekas, K. Stravodimos, R. Tauber, J.E. Geschwend, J. Neuhaus, J.U. Stolzenburg, M.R. Conaway, H. Mischak, and D. Theodorescu Prediction of muscle-invasive bladder cancer using urinary proteomics Clin. Cancer Res. 15 2009 4935
142. B.M. Schroeder ACOG practice bulletin on diagnosing and managing preeclampsia and eclampsia. American College of Obstetricians and Gynecologists Am. Fam. Physician 66 2002 330
143. J. Sherman, M.J. McKay, K. Ashman, and M.P. Molloy How specific is my SRM?: The issue of precursor and product ion redundancy Proteomics 9 2009 1120
144. T. Sigdel, A. Kaushal, M. Gritsenko, A. Norbeck, W. Xiao, W.J. Qian, D.G. Camp, and M. Sarwal Shotgun proteomics identifies proteins specific for acute renal transplant rejection Proteomics Clin. Appl. 4 2010 32
145. J. Siwy, W. Mullen, I. Golovko, J. Franke, and P. Zürbig Human urinary peptide database for multiple disease biomarker discovery Proteomics Clin. Appl. 5 2011 367
146. A. Stalmach, A. Albalat, W. Mullen, and H. Mischak Recent advances in capillary electrophoresis coupled to mass spectrometry for clinical proteomic applications Electrophoresis 34 2013 1452
147. K.K. Stamatelou, M.E. Francis, C.A. Jones, L.M. Nyberg, and G.C. Curhan Time trends in reported prevalence of kidney stones in the United States: 1976-1994 Kidney Int. 63 2003 1817
148. R. Star Design issues for clinical trials in acute renal failure Blood Purif. 19 2001 233
149. R.A. Star Treatment of acute renal failure Kidney Int. 54 1998 1817
150. M.B. Strader, D.L. Tabb, W.J. Hervey, C. Pan, and G.B. Hurst Efficient and specific trypsin digestion of microgram to nanogram quantities of proteins in organic-aqueous solvent systems Anal. Chem. 78 2006 125
151. M.H. Tayebjee, K.T. Tan, R.J. MacFadyen, and G.Y. Lip Abnormal circulating levels of metalloprotease 9 and its tissue inhibitor 1 in angiographically proven peripheral arterial disease: relationship to disease severity J. Intern. Med. 257 2005 110
152. C.F. Taylor, N.W. Paton, K.S. Lilley, P.A. Binz, R.K. Julian Jr., A.R. Jones, W. Zhu, R. Apweiler, R. Aebersold, E.W. Deutsch, M.J. Dunn, A.J. Heck, A. Leitner, M. Macht, M. Mann, L. Martens, T.A. Neubert, S.D. Patterson, P. Ping, S.L. Seymour, P. Souda, A. Tsugita, J. Vandekerckhove, T.M. Vondriska, J.P. Whitelegge, M.R. Wilkins, I. Xenarios, J.R. Yates III, and H. Hermjakob The minimum information about a proteomics experiment (MIAPE) Nat. Biotechnol. 25 2007 887
153. R. Thadhani, M. Pascual, and J.V. Bonventre Acute renal failure N. Engl. J. Med. 334 1996 1448
154. D. Theodorescu, D. Fliser, S. Wittke, H. Mischak, R. Krebs, M. Walden, M. Ross, E. Eltze, O. Bettendorf, C. Wulfing, and A. Semjonow Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine Electrophoresis 26 2005 2797
155. D. Theodorescu, E. Schiffer, H.W. Bauer, F. Douwes, F. Eichhorn, R. Polley, T. Schmidt, W. Schofer, P. Zürbig, D.M. Good, J.J. Coon, and H. Mischak Discovery and validation of urinary biomarkers for prostate cancer Proteomics Clin. Appl. 2 2008 556
156. D. Theodorescu, S. Wittke, M.M. Ross, M. Walden, M. Conaway, I. Just, H. Mischak, and H.F. Frierson Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis Lancet Oncol. 7 2006 230
157. V. Thongboonkerd Study of diabetic nephropathy in the proteomic era Contrib. Nephrol. 170 2011 172
158. K.M. Thrailkill, T. Nimmo, R.C. Bunn, G.E. Cockrell, C.S. Moreau, S. Mackintosh, R.D. Edmondson, and J.L. Fowlkes Microalbuminuria in type 1 diabetes is associated with enhanced excretion of the endocytic multiligand receptors megalin and cubilin Diabetes Care 32 2009 1266
159. E.C. Tsilibary Microvascular basement membranes in diabetes mellitus J. Pathol. 200 2003 537
160. M. Unlu, M.E. Morgan, and J.S. Minden Difference gel electrophoresis: a single gel method for detecting changes in protein extracts Electrophoresis 18 1997 2071
161. S.A. Varghese, T.B. Powell, M.G. Janech, M.N. Budisavljevic, R.C. Stanislaus, J.S. Almeida, and J.M. Arthur Identification of diagnostic urinary biomarkers for acute kidney injury J. Investig. Med. 58 2010 612
162. J. Villar, L. Say, A. Shennan, M. Lindheimer, L. Duley, A. Conde-Agudelo, and M. Merialdi Methodological and technical issues related to the diagnosis, screening, prevention, and treatment of pre-eclampsia and eclampsia Int. J. Gynaecol. Obstet. 85 Suppl. 1 2004 S28 S41 (Pubitemid 38625916)
163. A. Vlahou Back to the future in bladder cancer research Expert Rev. Proteomics 8 2011 295
164. A. Vlahou, J. Schanstra, J. Frokiaer, N.M. El, G. Spasovski, H. Mischak, B. Domon, G. Allmaier, E. Bongcam-Rudloff, and T. Attwood Establishment of a European network for urine and kidney proteomics J. Proteomics 71 2008 490
165. C. von Zur Muhlen, E. Schiffer, P. Zuerbig, M. Kellmann, M. Brasse, N. Meert, R.C. Vanholder, A.F. Dominiczak, Y.C. Chen, H. Mischak, C. Bode, and K. Peter Evaluation of Urine Proteome Pattern Analysis for Its Potential To Reflect Coronary Artery Atherosclerosis in Symptomatic Patients J. Proteome Res. 8 2009 335
166. C. von zur Muhlen, E. Schiffer, C. Sackmann, P. Zurbig, I. Neudorfer, A. Zirlik, N. Htun, A. Iphofer, L. Jansch, H. Mischak, C. Bode, Y.C. Chen, and K. Peter Urine proteome analysis reflects atherosclerotic disease in an ApoE -/- mouse model and allows the discovery of new candidate biomarkers in mouse and human atherosclerosis Mol. Cell. Proteomics 11 2012 M111
167. E.M. Weissinger, E. Schiffer, B. Hertenstein, J.L. Ferrara, E. Holler, M. Stadler, H.J. Kolb, A. Zander, P. Zürbig, M. Kellmann, and A. Ganser Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation Blood 109 2007 5511
168. J.R. Whiteaker, H. Zhang, L. Zhao, P. Wang, K.S. Kelly-Spratt, R.G. Ivey, B.D. Piening, L.C. Feng, E. Kasarda, K.E. Gurley, J.K. Eng, L.A. Chodosh, C.J. Kemp, M.W. McIntosh, and A.G. Paulovich Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer J. Proteome Res. 6 2007 3962
169. S. Wittke, M. Haubitz, M. Walden, F. Rohde, A. Schwarz, M. Mengel, H. Mischak, H. Haller, and W. Gwinner Detection of acute tubulointerstitial rejection by proteomic analysis of urinary samples in renal transplant recipients Am. J. Transplant. 5 2005 2479
170. S. Wittke, E. Schiffer, and H.W. Bauer Capillary electrophoresis coupled to mass spectrometry for proteome analysis: An innovative diagnostic method for prostate and bladder cancer Urologe A 46 2007 733
171. A. Wolf-Yadlin, S. Hautaniemi, D.A. Lauffenburger, and F.M. White Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks Proc. Natl. Acad. Sci. U. S. A. 104 2007 5860
172. C.A. Wright, S. Howles, D.C. Trudgian, B.M. Kessler, J.M. Reynard, J.G. Noble, F.C. Hamdy, and B.W. Turney Label-free quantitative proteomics reveals differentially regulated proteins influencing urolithiasis Mol. Cell. Proteomics 10 2011 M110
173. T. Yamamoto, R.G. Langham, P. Ronco, M.A. Knepper, and V. Thongboonkerd Towards standard protocols and guidelines for urine proteomics: a report on the Human Kidney and Urine Proteome Project (HKUPP) symposium and workshop, 6 October 2007, Seoul, Korea and 1 November 2007, San Francisco, CA, USA Proteomics 8 2008 2156
174. N. Yang, S. Feng, K. Shedden, X. Xie, Y. Liu, C.J. Rosser, D.M. Lubman, and S. Goodison Urinary glycoprotein biomarker discovery for bladder cancer detection using LC/MS-MS and label-free quantification Clin. Cancer Res. 17 2011 3349
175. H. Zhou, T. Pisitkun, A. Aponte, P.S. Yuen, J.D. Hoffert, H. Yasuda, X. Hu, L. Chawla, R.F. Shen, M.A. Knepper, and R.A. Star Exosomal fetuin-A identified by proteomics: A novel urinary biomarker for detecting acute kidney injury Kidney Int. 70 2006 1847
176. L.U. Zimmerli, E. Schiffer, P. Zürbig, M. Kellmann, L. Mouls, A. Pitt, J.J. Coon, R.E. Schmieder, H. Mischak, K. Peter, W. Kolch, C. Delles, and A.F. Dominiczak Urinary proteomics biomarkers in coronary artery disease Mol. Cell. Proteomics 7 2008 290
177. J. Zoidakis, M. Makridakis, P.G. Zerefos, V. Bitsika, S. Esteban, M. Frantzi, K. Stravodimos, N.P. Anagnou, M.G. Roubelakis, M. Sanchez-Carbayo, and A. Vlahou Profilin 1 is a potential biomarker for bladder cancer aggressiveness Mol. Cell. Proteomics 11 2012 (M111.009449)
178. P. Zürbig, S. Decramer, M. Dakna, J. Jantos, D.M. Good, J.J. Coon, F. Bandin, H. Mischak, J.L. Bascands, and J. Schanstra The human urinary proteome reveals high similarity between kidney aging and chronic kidney disease Proteomics 9 2009 2108
179. P. Zürbig, G. Jerums, P. Hovind, R. MacIsaac, H. Mischak, S.E. Nielsen, S. Panagiotopoulos, F. Persson, and P. Rossing Urinary Proteomics for Early Diagnosis in Diabetic Nephropathy Diabetes 61 2012 3304